The CD3ζ and CD28 signaling domains were established in two separate CAR and T lymphocyte lines and they simultaneously targeted tumor cells containing the antigens mesothelin and FRα (Lanitis et al., 2013). This evidence concerns the gene MSLN and neoplasm.